Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101891571A details a Pd-catalyzed carbonylation route for unsaturated ketones. Offers high purity intermediates and streamlined supply chain solutions.
Novel synthesis of iridium acetylacetonate complex offers high purity and scalable production for industrial catalysis applications.
Novel carbonyl insertion method using N-formyl saccharin avoids toxic CO gas, offering safe, scalable production of alkynone intermediates.
Patent CN116730813A reveals a safer Grignard route for 4,4'-Difluorobenzophenone. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel biomass-derived route for polyamide intermediates. Reduces energy and waste via catalytic hydroformylation and carbonylation technology.
Novel one-pot carbonylation method enhances purity and yield for pharmaceutical intermediates, offering significant supply chain stability and cost efficiency.
Patent CN119462433A details high-selectivity urea synthesis. Offers supply chain stability and cost efficiency for agrochemical intermediate manufacturing partners globally.
Patent CN104803905B reveals high-yield Pd-catalyzed route. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel Pd-pyridine catalysis enables mild, high-yield benzodiazepine production. Reduces catalyst loading and operational costs for pharmaceutical intermediates.
Patent CN103833565B enables one-pot synthesis with high purity. Delivers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Patent CN103420870A details a novel carbonylation route for high-purity chiral 4-cyano-3-hydroxybutyrate, offering significant cost reduction and scalable manufacturing for statin intermediates.
Patent CN120247907A details improved synthesis for IAP antagonist intermediate (XXIII). Enhanced purity, stability, and supply chain reliability for pharmaceutical manufacturing.
Patent CN113801045A details a novel Pd-catalyzed carbonylation route for 2-nitro-4-methylsulfonylbenzoic acid, offering safer, high-purity production for agrochemical supply chains.
Patent CN101219972A details a non-phosgene route for symmetrical aryl urea using SeO2. Offers safer, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109320413A reveals a mixed catalyst system for phenylacetic acid. This method ensures high purity and safer manufacturing for global supply chains.
Advanced selenium-catalyzed method for monosulfide synthesis using CO and water. Offers high purity, atmospheric pressure operation, and significant cost reduction for pharmaceutical intermediates.
Patent CN104583174B reveals high-yield α-fluoroacrylate production. Enhance supply chain reliability and reduce manufacturing costs with this novel carbonylation method.
Patent CN1419538A details a novel catalytic process for aromatic isocyanates, offering significant cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Patent CN112851508A details a safe, scalable route to 3,4-difluoro-2-methylbenzoic acid, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.